Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,549 active trials61 approved drugs295 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,963)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06253091 | Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy | unknown | N/A | 50 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT03924466 | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients(VUBAR) | unknown | Phase 2 | 55 | Universitair Ziekenhuis BrusselOTHER | 1 | Feb 16, 2024 |
| clinicaltrials |
| NCT06148220 | A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors | unknown | N/A | 20 | Huashan HospitalOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06263062 | Management With Fear of Cancer in Women Undergoing Colposcopy: Randomized Controlled Study | unknown | N/A | 60 | Alanya Alaaddin Keykubat UniversityOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06261879 | Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstrual Blood | unknown | N/A | 300 | WomenX Biotech LimitedINDUSTRY | 1 | Feb 15, 2024 | clinicaltrials |
| NCT06261892 | Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine | unknown | N/A | 300 | WomenX Biotech LimitedINDUSTRY | 1 | Feb 15, 2024 | clinicaltrials |
| NCT04145388 | Family History Study on Cancer Risk | unknown | N/A | 18,623 | Kaiser PermanenteOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT02730923 | Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)(VICTORIA) | unknown | Phase 1 / Phase 2 | 72 | Centre Leon BerardOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT05829057 | The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 | unknown | Phase 1 | 10 | Zhejiang UniversityOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT05587192 | Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic Model(RPWPB) | unknown | N/A | 57 | Anhui Provincial HospitalOTHER_GOV | 1 | Feb 12, 2024 | clinicaltrials |
| NCT06250686 | Exercise and Nutrition Intervention in Ovarian Cancer(BENITA) | unknown | N/A | 185 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Feb 9, 2024 | clinicaltrials |
| NCT03899077 | Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP(SAVE) | unknown | Phase 2 | 202 | Cancer Research AntwerpOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT04149691 | Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies | unknown | Phase 1 | 42 | Celon Pharma SAINDUSTRY | 1 | Feb 7, 2024 | clinicaltrials |
| NCT06069648 | Effects of Decision Aids on the Participation of South Asian Women in Cervical Cancer Screening | unknown | N/A | 270 | Chinese University of Hong KongOTHER | 0 | Feb 7, 2024 | clinicaltrials |
| NCT06245759 | The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients | unknown | — | 120,000 | Huazhong University of Science and TechnologyOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05189028 | Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer | unknown | Phase 3 | 290 | Chuangzhen ChenOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT06243185 | Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors | unknown | Phase 2 | 30 | Fengzhi FengOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT05947188 | Circulating Tumor Cells and mpMRI for Non-invasive Diagnosis of Prostate Cancer(CMNDPC)(CMNDPC) | unknown | N/A | 808 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Feb 5, 2024 | clinicaltrials |
| NCT06241105 | Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer | unknown | Phase 2 | 69 | Peking Union Medical College HospitalOTHER | 1 | Feb 5, 2024 | clinicaltrials |
| NCT04599218 | MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer | unknown | N/A | 1,586 | Ardeshir RastinehadOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT04656678 | Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer | unknown | N/A | 200 | Northwell HealthOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT05787535 | HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor | unknown | Phase 1 | 17 | HRYZ Biotech Co.INDUSTRY | 1 | Feb 2, 2024 | clinicaltrials |
| NCT06238284 | HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China | unknown | — | 300 | Chongqing University Cancer HospitalOTHER | 0 | Feb 2, 2024 | clinicaltrials |
| NCT05212779 | Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease | unknown | — | 45 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)OTHER | 1 | Feb 1, 2024 | clinicaltrials |
| NCT06208319 | Development and Evaluation of an Artificial Intelligence Tool for Colposcopy Assistance(IACOL) | unknown | — | 1,000 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Feb 1, 2024 | clinicaltrials |
| NCT06236958 | Effect of Early Enteral Nutrition on Postoperative Recovery of Ovarian Cancer Patients | unknown | — | 200 | Luo ChengyanOTHER | 1 | Feb 1, 2024 | clinicaltrials |
| NCT05940415 | Conducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate Cancer(ASWBP) | unknown | — | 220 | Anhui Provincial HospitalOTHER_GOV | 1 | Jan 31, 2024 | clinicaltrials |
| NCT06234670 | Risk Factors and A Prediction Model of Recurrence of Uterine Fibroids | unknown | — | 3,200 | Wenwen WangOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT06235268 | Prospective and Multicenter Italian Registry of Locally Advanced-Metastatic Urothelial Carcinoma | unknown | — | 1,000 | Federation of Italian Cooperative Oncology GroupsOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT05193656 | Bladder Cancer Detection Using Convolutional Neural Networks(BLAInostic) | unknown | — | 5,000 | Zealand University HospitalOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT05452824 | Participating in Tai Chi to Reduce Anxiety and Keep up Physical Function(PEAK-RP) | unknown | N/A | 40 | AHS Cancer Control AlbertaOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT04470921 | STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands(STOPOVCA) | unknown | — | 10,000 | Radboud University Medical CenterOTHER | 1 | Jan 26, 2024 | clinicaltrials |
| NCT05489926 | A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure | unknown | Phase 2 | 15 | Zhejiang Cancer HospitalOTHER | 1 | Jan 26, 2024 | clinicaltrials |
| NCT04693169 | [Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients | unknown | N/A | 20 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT05738902 | Adherence and Compliance to ERAS in Gynecological Surgery(ERASGYNBS002) | unknown | — | 600 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT06223308 | A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 54 | Shanghai Huaota Biopharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 25, 2024 | clinicaltrials |
| NCT06223763 | SUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive Surgery(SUROVA) | unknown | — | 5,000 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT01864096 | The Metformin Active Surveillance Trial (MAST) Study(MAST) | unknown | Phase 3 | 408 | University Health Network, TorontoOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT03432949 | Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC(TRANCE) | unknown | Phase 4 | 24 | University Health Network, TorontoOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT06221774 | Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors | unknown | Phase 1 / Phase 2 | 42 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT06222008 | Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution | unknown | — | 40 | Yandi ZhuOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT06182644 | Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors(FAPI) | unknown | N/A | 30 | Guangdong Provincial People's HospitalOTHER | 1 | Jan 22, 2024 | clinicaltrials |
| NCT05916690 | Electrochemotherapy for the Treatment of Vulvar Cancer | unknown | N/A | 20 | Institute of Oncology LjubljanaOTHER | 1 | Jan 19, 2024 | clinicaltrials |
| NCT05084677 | Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer | unknown | Phase 2 | 96 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT06211023 | A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer | unknown | Phase 2 / Phase 3 | 520 | Suzhou Suncadia Biopharmaceuticals Co., Ltd.INDUSTRY | 0 | Jan 18, 2024 | clinicaltrials |
| NCT05065021 | Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor | unknown | Phase 2 | 40 | University Health Network, TorontoOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT04994197 | Urothelial Tumor Risk Genes Detection With Genetron Uro V1 and LC-WGS | unknown | — | 970 | Ruijin HospitalOTHER | 1 | Jan 10, 2024 | clinicaltrials |
| NCT05584787 | Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis | unknown | N/A | 20 | San Carlo di Nancy HospitalOTHER | 1 | Jan 10, 2024 | clinicaltrials |
| NCT05161728 | PSMA Response in Metastasized Hormone Sensitive Prostate Cancer(PET-MaN) | unknown | N/A | 150 | Roderick van den BerghOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT05539300 | PSMA Response in Metastasized Hormone Sensitive Prostate Cancer - Enzalutamide(PET-MaN-enza) | unknown | N/A | 150 | UMC UtrechtOTHER | 1 | Jan 9, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Feb 20, 2024source: clinicaltrials